A systematic literature review of herpes zoster incidence worldwide.
Incidence
adults
epidemiology
herpes zoster
review
shingles
vaccination
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
03 06 2021
03 06 2021
Historique:
pubmed:
3
3
2021
medline:
6
7
2021
entrez:
2
3
2021
Statut:
ppublish
Résumé
We conducted a systematic review to characterize the incidence rate of herpes zoster (HZ) in the general population, specifically in individuals ≥50 years of age. A total of 69 publications were included in the review. We found a cumulative incidence of HZ ranging from 2.9-19.5 cases per 1,000 population and an incidence rate of HZ ranging from 5.23-10.9 cases per 1,000 person-years. The cumulative incidence (3.22-11.2 versus 2.44-8.0 cases per 1,000 population) and incidence rates (6.05-12.8 versus 4.30-8.5 cases per 1,000 person-years) were higher in females than males. Studies revealed a trend of increasing incidence of HZ with increasing age and over time. Variations in incidence estimates can be attributed to the various study designs, case ascertainments, age distributions of the population and year of the study. HZ is associated with a substantial disease burden and is expected to increase due to population aging.
Identifiants
pubmed: 33651654
doi: 10.1080/21645515.2020.1847582
pmc: PMC8115759
doi:
Substances chimiques
Herpes Zoster Vaccine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1714-1732Références
J Infect. 2013 Nov;67(5):463-9
pubmed: 23872209
Vaccine. 2010 Feb 3;28(5):1217-20
pubmed: 19944790
BMJ Open. 2018 May 31;8(5):e021241
pubmed: 29858420
BMC Infect Dis. 2016 Jun 07;16:254
pubmed: 27266273
MMW Fortschr Med. 2010 Jan 14;151 Suppl 4:193-7
pubmed: 21595148
J Infect. 2015 Feb;70(2):178-86
pubmed: 25230396
J Med Virol. 2003;70 Suppl 1:S9-14
pubmed: 12627480
Mayo Clin Proc. 2007 Nov;82(11):1341-9
pubmed: 17976353
Przegl Epidemiol. 2015;69(4):693-7, 841-3
pubmed: 27139346
Fam Pract. 2005 Oct;22(5):523-8
pubmed: 16006497
J Epidemiol. 2015;25(10):617-25
pubmed: 26399445
PLoS One. 2015 Apr 30;10(4):e0125025
pubmed: 25928713
Dermatol Ther (Heidelb). 2019 Mar;9(1):117-133
pubmed: 30456446
Clin Infect Dis. 2019 Jul 2;69(2):341-344
pubmed: 30496358
Eur J Health Econ. 2013 Dec;14(6):1015-26
pubmed: 23271349
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
pubmed: 18528318
BMJ Open. 2014 Jun 10;4(6):e004833
pubmed: 24916088
J Infect. 2018 May;76(5):475-482
pubmed: 29428228
J Korean Med Sci. 2014 Dec;29(12):1706-10
pubmed: 25469074
Infection. 2014 Apr;42(2):325-34
pubmed: 24214127
J Dermatol Sci. 2018 Oct;92(1):89-96
pubmed: 30041832
Epidemiol Infect. 2015 Oct;143(13):2871-81
pubmed: 25592769
Ann Epidemiol. 2006 Sep;16(9):692-5
pubmed: 16516488
BMC Infect Dis. 2015 Oct 31;15:488
pubmed: 26520060
PLoS One. 2016 Apr 07;11(4):e0152660
pubmed: 27055179
Hum Vaccin Immunother. 2017 Nov 2;13(11):2606-2611
pubmed: 28933622
J Infect. 2014 Apr;68(4):378-86
pubmed: 24247069
Lancet Public Health. 2018 Feb;3(2):e82-e90
pubmed: 29276017
BMC Geriatr. 2017 Jan 23;17(1):30
pubmed: 28114907
J Gen Intern Med. 2005 Aug;20(8):748-53
pubmed: 16050886
Epidemiol Infect. 2005 Apr;133(2):245-53
pubmed: 15816149
An Sist Sanit Navar. 2008 Jan-Apr;31(1):71-80
pubmed: 18496581
BMC Fam Pract. 2010 May 06;11:33
pubmed: 20459608
BMC Infect Dis. 2013 Oct 05;13:463
pubmed: 24094135
Open Forum Infect Dis. 2017 Jan 28;4(1):ofx007
pubmed: 28480280
Epidemiol Infect. 2001 Oct;127(2):305-14
pubmed: 11693508
Pharmacoeconomics. 2007;25(1):3-6
pubmed: 17192114
Epidemiol Infect. 2009 Jan;137(1):38-47
pubmed: 18466661
Vaccine. 2010 Nov 23;28(50):7933-8
pubmed: 20946861
Vaccine. 2017 Oct 9;35(42):5589-5596
pubmed: 28874322
N Z Med J. 2014 Dec 19;127(1407):56-60
pubmed: 25530332
PLoS Med. 2013;10(4):e1001420
pubmed: 23585738
Public Health Rep. 2007 Mar-Apr;122(2):155-9
pubmed: 17357357
BMC Infect Dis. 2015 Nov 06;15:502
pubmed: 26546419
Open Forum Infect Dis. 2014 Aug 02;1(2):ofu049
pubmed: 25734121
BMC Public Health. 2005 Jun 16;5:68
pubmed: 15960856
Vaccine. 2014 Oct 29;32(47):6319-24
pubmed: 24099868
Vaccine. 2007 Oct 23;25(43):7598-604
pubmed: 17889410
BMC Public Health. 2018 Mar 20;18(1):369
pubmed: 29554872
Hum Vaccin Immunother. 2015;11(8):2113-8
pubmed: 26020733
Vaccine. 2009 Jan 22;27(4):520-9
pubmed: 19027048
Proc R Soc Med. 1965 Jan;58:9-20
pubmed: 14267505
Clin J Pain. 2010 Oct;26(8):656-66
pubmed: 20842005
BMC Infect Dis. 2015 May 22;15:215
pubmed: 26002038
BMC Infect Dis. 2016 Oct 20;16(1):589
pubmed: 27765026
Hum Vaccin Immunother. 2017 Feb;13(2):399-404
pubmed: 27925843
Can Commun Dis Rep. 2007 Nov 1;33(11):1-15
pubmed: 18163240
Mayo Clin Proc. 2017 Dec;92(12):1806-1821
pubmed: 29202939
J Med Virol. 2009 Dec;81(12):2053-8
pubmed: 19856466
Vaccine. 2011 Nov 3;29(47):8580-4
pubmed: 21939721
Br J Dermatol. 2018 Jun;178(6):1324-1330
pubmed: 29388189
Ann Intern Med. 2013 Dec 3;159(11):739-45
pubmed: 24297190
Hum Vaccin Immunother. 2014;10(8):2460-7
pubmed: 25424956
Vaccine. 2018 Apr 19;36(17):2371-2377
pubmed: 29555217
Clin Infect Dis. 2011 Feb 1;52(3):332-40
pubmed: 21217180
Epidemiol Infect. 2012 Jun;140(6):1131-40
pubmed: 21906410
Rev Epidemiol Sante Publique. 2010 Dec;58(6):393-401
pubmed: 21094001
Epidemiol Infect. 2007 Aug;135(6):908-13
pubmed: 17291380
Fam Pract. 2002 Oct;19(5):471-5
pubmed: 12356697
Vaccine. 2017 Dec 15;35(50):6984-6989
pubmed: 29128385
Herpes. 2007 Sep;14 Suppl 2:35-9
pubmed: 17939894
Clin Infect Dis. 2016 Jul 15;63(2):221-6
pubmed: 27161774
BMC Infect Dis. 2011 Jun 16;11:173
pubmed: 21679419
BMC Infect Dis. 2012 May 10;12:110
pubmed: 22574722
BMC Infect Dis. 2010 Aug 03;10:230
pubmed: 20682044
Hum Vaccin Immunother. 2018;14(11):2632-2635
pubmed: 30059639
Eur J Epidemiol. 2004;19(12):1113-8
pubmed: 15678791
Acta Derm Venereol. 2009 Nov;89(6):612-6
pubmed: 19997693